ELEV - Elevation Oncology, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts3333
Avg. Estimate-0.32-0.36-1.65-1.59
Low estimate-0.41-0.43-1.9-2.2
High estimate-0.25-0.25-1.28-1.02
Year ago EPS-0.86-1.67-4.09-1.65
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.79-1.3-0.78-0.59
Actual EPS-0.86-1.67-0.82-0.72
Difference-0.07-0.37-0.04-0.13
Surprise %-8.90%-28.50%-5.10%-22.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.32-0.36-1.65-1.59
7 days ago-0.32-0.36-1.65-1.59
30 days ago-0.48-0.48-1.87-1.54
60 days ago-0.48-0.48-1.87-1.54
90 days ago-0.59-0.51-2.07-1.64
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesELEVIndustrySector(s)S&P 500
Current qtr.62.80%N/AN/AN/A
Next qtr.78.40%N/AN/AN/A
Current year59.70%N/AN/AN/A
Next year3.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A